Improvement in purification & automation process and less generation of waste is an additional factor
attributing toward market growth
Further Key Findings From the Study Suggest:
•
•
•
•
•
Cancer held the largest market share in 2016 owing to increasing demand for alternative therapeutics
over conventional treatment options. Peptides are being used as potential therapeutic agents in cancer
treatment.
The generic drug segment is expected to showcase upward shift due to patent expiration of
blockbuster peptides and supportive government initiatives pertaining to the introduction of generic
class
Outsourced manufacturing is expected to grow at CAGR of 6.7% owing to requirements of complex
procedures and shift in preference toward outsourcing, which helps in eliminating cost of production.
Route of administration including nasal and intradermal routes is expected to grow at a rapid pace
owing to ease of usage and advantages over other routes of administration such as oral.
Hybrid technology is expected to spearhead the growth of this market. Benefits associated with this
technology such as time conservation and ease of usage for both solid- and liquid-phase peptide
synthesis are the key factors affirming growth.
Request A Sample copy of This Report @
https://www.hexareports.com/report/peptide-therapeutics-market/request-sample
•
•
•
North America held the largest share in terms of revenue in 2016 owing to higher level of awareness
pertaining to genomics & proteomics products, well-established R&D infrastructure, and rising funding
initiatives
Asia Pacific industry is expected to showcase lucrative growth over the forecast period with CAGR of
11.0%. Presence of established generic industry and API providers in this region coupled with growing
economic stability in some of the countries is expected to propel market growth.
Some of the key players in the peptide therapeutics market include Eli Lilly and Company; Pfizer, Inc.;
Amgen, Inc.; Takeda Pharmaceutical Company Limited; Teva Pharmaceuticals Industries Ltd.; Lonza
Inc.; Sanofi; Bristol-Myers Squibb (BMS); AstraZeneca PLC; GlaxoSmithKline plc (GSK); Novartis AG; and
Novo Nordisk A/S
Browse More Pharmaceutical Related Market Research Reports:
• Central Nervous System (CNS) Therapeutic Market Analysis By Disease Type (Neurovascular Diseases,
Trauma, Mental Health, Degenerative Disorder [Alzheimer's Diseases, Parkinson's Diseases, Multiple
Sclerosis], Infections, Cancer), And Segment Forecasts, 2016 - 2025-
https://www.hexareports.com/report/central-nervous-system-cns-therapeutic-market
Follow Us: